Investigative Ophthalmology & Visual Science Cover Image for Volume 64, Issue 8
June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Prediction of visual field progression based on initial OCT structure measurements using Artificial Intelligence
Author Affiliations & Notes
  • Sasan Moghimi
    Viterbi Family Department of Ophthalmology, 1Hamilton Glaucoma Center, Shiley Eye Institute, UC San Diego, LA JOLLA, California, United States
  • Golnoush Mahmoudinezhad
    Viterbi Family Department of Ophthalmology, 1Hamilton Glaucoma Center, Shiley Eye Institute, UC San Diego, LA JOLLA, California, United States
  • V. S. Raghu Parupudi
    Electrical and Computer Engineering, University of California San Diego, La Jolla, California, United States
  • Vyshnavi S Krishan
    Electrical and Computer Engineering, University of California San Diego, La Jolla, California, United States
  • Siddharth Shukla
    Electrical and Computer Engineering, University of California San Diego, La Jolla, California, United States
  • Jiacheng Cheng
    Electrical and Computer Engineering, University of California San Diego, La Jolla, California, United States
  • Siavash Beheshtaein
    L3Harris Technologies, Torrance, California, United States
  • Kareem Latif
    Viterbi Family Department of Ophthalmology, 1Hamilton Glaucoma Center, Shiley Eye Institute, UC San Diego, LA JOLLA, California, United States
  • Takashi Nishida
    Viterbi Family Department of Ophthalmology, 1Hamilton Glaucoma Center, Shiley Eye Institute, UC San Diego, LA JOLLA, California, United States
  • Mark Christopher
    Viterbi Family Department of Ophthalmology, 1Hamilton Glaucoma Center, Shiley Eye Institute, UC San Diego, LA JOLLA, California, United States
  • Massimo A Fazio
    opthalmology, Bernard School of Medicine, University of Alabama-Birmingham,, Birmingham, Alabama, United States
  • Jeffrey M Liebmann
    opthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Christopher A Girkin
    opthalmology, Bernard School of Medicine, University of Alabama-Birmingham,, Birmingham, Alabama, United States
  • Linda M Zangwill
    Viterbi Family Department of Ophthalmology, 1Hamilton Glaucoma Center, Shiley Eye Institute, UC San Diego, LA JOLLA, California, United States
  • Nuno Vasconcelos
    Electrical and Computer Engineering, University of California San Diego, La Jolla, California, United States
  • Robert N Weinreb
    Viterbi Family Department of Ophthalmology, 1Hamilton Glaucoma Center, Shiley Eye Institute, UC San Diego, LA JOLLA, California, United States
  • Footnotes
    Commercial Relationships   Sasan Moghimi None; Golnoush Mahmoudinezhad None; V. S. Raghu Parupudi None; Vyshnavi S Krishan None; Siddharth Shukla None; Jiacheng Cheng None; Siavash Beheshtaein None; Kareem Latif None; Takashi Nishida Topcon, Code C (Consultant/Contractor); Mark Christopher AISight Health, Code P (Patent); Massimo Fazio National Eye Institute, EyeSight Foundation of Alabama, Research to Prevent Blindness, Heidelberg Engineering, GmbH, Topcon and Wolfram Research, Code F (Financial Support); Jeffrey Liebmann Allergan, Genentech, Thea, Bausch & Lomb, Code C (Consultant/Contractor), Novartis, Research to Prevent Blindness , Code F (Financial Support); Christopher Girkin National Eye Institute,Heidelberg Engineering and Topcon, EyeSight Foundation of Alabama, Research to Prevent Blindness, Heidelberg Engineering, GmbH, Code F (Financial Support); Linda Zangwill Abbvie Inc. Topcon, Code C (Consultant/Contractor), National Eye Institute, Carl Zeiss Meditec Inc., Heidelberg Engineering GmbH, Optovue Inc., Topcon Medical Systems Inc., Code F (Financial Support), Zeiss Meditec, AISight Health , Code P (Patent); Nuno Vasconcelos Amazon, Nautilus cluster, Code F (Financial Support); Robert Weinreb Abbvie, Aerie Pharmaceuticals, Allergan, Equinox, Iantrek, Implandata, Nicox, Topcon Medical , Code C (Consultant/Contractor), Bausch & Lomb, Topcon Medical, Heidelberg Engineering, Carl Zeiss Meditec, Optovue, Centervue, Code F (Financial Support), Toromedes, Carl Zeiss Meditec, Code P (Patent)
  • Footnotes
    Support  R01EY034148, EY029058, EY11008, P30 EY022589, EY026574, Tobacco: Tobacco-Related Disease Research Program T31IP1511,Research to Prevent Blindness
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 370. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sasan Moghimi, Golnoush Mahmoudinezhad, V. S. Raghu Parupudi, Vyshnavi S Krishan, Siddharth Shukla, Jiacheng Cheng, Siavash Beheshtaein, Kareem Latif, Takashi Nishida, Mark Christopher, Massimo A Fazio, Jeffrey M Liebmann, Christopher A Girkin, Linda M Zangwill, Nuno Vasconcelos, Robert N Weinreb; Prediction of visual field progression based on initial OCT structure measurements using Artificial Intelligence. Invest. Ophthalmol. Vis. Sci. 2023;64(8):370.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate the ability of macular and circumpapillary retinal nerve fiber (cpRNFL) baseline and longitudinal optical coherence tomography (OCT) structural measures during an initial follow-up period to predict visual field (VF) progression using machine learning (ML) approach.

Methods : 204 eyes of 126 patients with glaucoma were included. Rates of change of the macular ganglion cell complex (GCC) layer superpixels and regional cpRNFL thickness from OCT were calculated from initial 5 OCT visits. VF progression was evaluated with event-based analysis; two consecutive significant negative slopes from VF mean deviation during the entire follow-up period. 4-fold cross-validation evaluation was applied to each ML model. Different ML models including ridge regression (RR), random forests (RF), support vector machine (SVM), gradient boosting machine (GBM), and Naïve Bayes (NB) were fitted for structural baseline and rates of change; and clinical/demographic parameters to predict visual field (VF) progression and compared with logistic regression (LR) model using paired bootstrap test.

Results : 20 eyes developed VF progression in an average 7.3 years. Average rates of GCC and cpRNFL rates –) were significantly faster in eyes with VF progression than those that never progressed [– 2.09 μm/year (95% CI, −3.40 to −0.80, P=0.001and 0.79μm/year (95% CI, −1.5 to −0.1, P=0.030, respectively)]. The AUC (95% CI) for the prediction of VF progression was 0.81(0.62, 0.98), 0.77(0.57, 0.97), 0.76(0.53, 0.96), 0.74 (0.42, 0.98), 0.66 (0.45, 0.90), and 0.58(0.23,-0.92) for RR, RF, SVM, NB, GBM, and LR respectively (Figure 1). RR (P=0.001), RF(P=0.001), SVM (P=0.009), and NB(P=0.04) outperformed LR for predicting VF progression. Predictive factors that were selected by RR were sectors 10,11, 14, 15, 20, and 21 from cpRNFL, race, and spherical equivalent. Parameters with the highest relative importance from RF were shown in Figure 2.

Conclusions : VF progression in glaucoma eyes can be predicted from baseline, longitudinal macular, and cpRNFL OCT data along with clinical/demographic data during an initial follow-up period using ML models with good accuracy. The proposed longitudinal ML models may assist clinicians in predicting patients at high risk of developing functional disability.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×